Top News

Kalypsys Appoints CEO

San Diego-based Kalypsys, a drug discovery company focused on developing new medicines for cancer, inflammation, and metabolic diseases, has named a new CEO. Dr. John McKearn, the company's Chief Scientific Officer, has been promoted to CEO. McKearn was previously at Pharmacia, as well as G.D. Searle.


 

Marketplace


 

 

Latest Headlines

Browse Issues

 
 

Keep up with all of the latest Southern California high tech news via email (it's free!)



or Cancel